Trial intelligence / Profile preview

Ivabradine in Hemodialysis Patients with HFNEF

NCT01373619Phase 4Completed

Sponsor
University of Campania Luigi Vanvitelli
Start
Jan 2010
Primary completion
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ivabradine in heart failure with preserved ejection fraction (HFpEF), sponsored by University of Campania Luigi Vanvitelli. Started Jan 2010; status: completed.

02

Drugs

ivabradine
03

Conditions

heart failure with preserved ejection fraction (HFpEF)

Beyond the preview

Go deeper on NCT01373619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01373619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call